David Eidelberg, MD, is Director of the Feinstein Center for Neurosciences and heads the National Institutes of Health (NIH) Morris K. Udall Center of Excellence for Parkinson’s Disease Research at the Feinstein Institute.
He is internationally recognized for his pioneering work using neuroimaging to detect network abnormalities in Parkinson’s and dystonia. In 1993, Dr. Eidelberg and colleagues published the first PET imaging study of XDP patients suggesting metabolic defects in the striatum. His work has led to the development of novel imaging methods for differential diagnosis and for the accurate assessment of disease progression and the response to treatment.
Dr. Eidelberg received his medical degree from Harvard Medical School. After completing residency training in neurology at Harvard, he pursued postdoctoral training in brain imaging in London and New York. In 1988 he established a functional imaging laboratory and the clinical movement disorders program at The Feinstein Institute. In 2001, he became the director of the new Center for Neurosciences at The Feinstein Institute, where he is currently professor of neurology and neuroscience.
He has authored over 350 peer-reviewed research articles, editorials, and reviews, as well as a textbook (Brain Imaging in Parkinson’s Disease, Oxford University Press 2011). He serves as scientific advisor to the Collaborative Center for XDP, the Michael J. Fox Foundation, the U.S. Department of Defense, and the COBRE Center for Neurodegeneration and Translational Neuroscience (CNTN). He is the recipient of the Fred Springer Award and the American Academy of Neurology Movement Disorders Research Award.
Support Our Work
Your contribution helps provide care and advance research for XDP patients, especially those who cannot access sufficient medical care and social resources.